Unlocking the Mystery: How Axial Spondyloarthritis Impacts Women Differently
"New insights reveal why women with axial spondyloarthritis often face unique diagnostic and treatment challenges."
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. While it's known to cause pain, stiffness, and reduced mobility, emerging research highlights that axSpA can present differently in women, leading to potential delays in diagnosis and tailored management strategies. Understanding these nuances is crucial for empowering women to seek timely and effective care.
Historically, axSpA, particularly its radiographic form known as ankylosing spondylitis (AS), was considered more prevalent in men. However, recent studies suggest that non-radiographic axSpA (nr-axSpA), where joint damage is not yet visible on X-rays, might be more common in women. This distinction is important because diagnostic criteria and treatment approaches may vary depending on whether the condition is radiographic or non-radiographic.
This article aims to explore the latest findings on how axSpA affects women, focusing on the similarities and differences in symptoms, diagnostic challenges, and treatment considerations. By shedding light on these aspects, we hope to provide valuable information for women living with axSpA, their families, and healthcare providers.
A Higher Disease Burden in Women
Axial spondyloarthritis (axSpA) is part of a group of inflammatory diseases that cause arthritis, primarily affecting the spine and sacroiliac joints. Investigators have found that women with axSpA carry an overall higher disease burden and experience more peripheral manifestations when compared with men. These differences mean the condition often shows up differently in women, which can complicate recognition and care.
Why Standard Diagnosis Can Miss Women
Axial spondyloarthritis diagnostic criteria often fail to consider sex differences between men and women. Because women's symptoms frequently present in a different way from men's, the methods used to diagnose axSpA may overlook or misread their disease. This gap in the accepted approach helps explain why axSpA is commonly underdiagnosed in women.
From Ankylosing Spondylitis to AxSpA
Axial spondyloarthritis, also historically called ankylosing spondylitis (AS), has long been recognized as a condition that affects the spine and its supporting joints. Patients may face real challenges with everyday movements such as walking, getting out of bed, and bending forward. Epidemiology reports on axSpA continue to build on foundational work that defines the disease's causes and typical symptoms.
The Diagnostic Maze: Recognizing axSpA in Women
One of the significant challenges in managing axSpA in women is the potential for delayed or missed diagnoses. Women often experience a different symptom profile compared to men, which can lead to misdiagnosis or a delay in recognizing axSpA. Common symptoms reported by women include:
- Greater prevalence of peripheral joint involvement: Women may experience more pain and inflammation in joints outside the spine, such as the hands, feet, or knees.
- Higher rates of enthesitis: Inflammation at the sites where tendons and ligaments attach to bone (enthesitis), particularly in the heels or feet, may be more frequent in women.
- Increased fatigue and fibromyalgia-like symptoms: Women may experience more pronounced fatigue, widespread pain, and other symptoms that overlap with fibromyalgia, making diagnosis more complex.
- Lower levels of elevated CRP: Traditional markers of inflammation, such as C-reactive protein (CRP), may not be as elevated in women with nr-axSpA, potentially leading to a missed diagnosis.
New Findings on Women's Higher Disease Burden
Recent investigations report that women with axial spondyloarthritis have an overall higher disease burden and more peripheral manifestations compared with men. A real-life prospective cohort study also found sex-based differences in clinical characteristics and treatment effectiveness among people with nonradiographic axial spondyloarthritis, with women often not benefiting as much from biologic therapy. These findings are pushing researchers to look more closely at how sex shapes both disease expression and treatment outcomes.
Where Standard Care Falls Short
A striking failure in current care is that women with nonradiographic axial spondyloarthritis don't benefit from biologics as much as men, according to data from a prospective cohort study. This may be partly because diagnostic criteria often fail to account for sex differences, and women's symptoms tend to present differently from men's. As a result, women are more likely to face underdiagnosis and may not receive the most effective treatment early enough.
Men Versus Women: Key Differences
Women with axial spondyloarthritis show a higher disease burden and more peripheral manifestations than men, while men more often present with the classic spinal picture of the disease. It's not fully known how sex mediates these downstream effects, but sex hormones are recognized to have specific influences on the immune system. These differences matter because they shape everything from symptoms and diagnosis to how well treatments work.
Empowering Women with axSpA: A Path Forward
Understanding the unique ways axSpA affects women is essential for improving diagnostic accuracy and treatment outcomes. By raising awareness and promoting further research, we can empower women to take control of their health and live fulfilling lives despite the challenges of axSpA. Early diagnosis, personalized treatment strategies, and ongoing support are key to managing the condition effectively.
What Experts Say About Managing AxSpA
Experts describe axial spondyloarthritis as a condition that affects the axial skeleton, and they emphasize the importance of understanding what causes it, how it affects the body, and how it is treated. Commentary in the field points to treatment strategies that range from medication and biologic therapy to physiotherapy and lifestyle management. Because women's experience of the disease differs, expert guidance increasingly stresses individualized approaches.
Better Data, Better Care Ahead
Epidemiology forecasts are giving a clearer picture of axial spondyloarthritis, with reports projecting the disease landscape through 2030 by including details such as disease definition and symptoms. This improved data is expected to support earlier recognition of the condition in underrepresented groups, including women. Future research directions will likely focus on closing the sex-based gaps in diagnosis and treatment response.
A System That Overlooks Women
A systemic challenge in axial spondyloarthritis is that diagnostic criteria often fail to consider sex differences, and the methods used to diagnose the disease may not capture how women's symptoms present. This contributes to the well-documented underdiagnosis of axSpA in women. Addressing these systemic gaps will require updated criteria and greater awareness among clinicians that the disease does not look the same in every patient.
Life With Axial Spondyloarthritis
For people living with axial spondyloarthritis, everyday movements like walking, getting out of bed, and bending forward can become genuine struggles. Many seek answers to questions about chronic back pain and whether biologic therapy can help manage their condition. Patient organizations, such as the Axial Spondyloarthritis Association of South Africa, work to connect those affected with support and education.